|
|
||||||||
J Thorac Cardiovasc Surg 2005;130:1511-1516
© 2005 The American Association for Thoracic Surgery
Surgery for Congenital Heart Disease |
a Divisions of Cardiology, General Pediatrics
b Neurology
c Psychology
d Genetics
e Cardiothoracic Surgery
f Department of Anesthesia and Critical Care Medicine
g The Children's Hospital of Philadelphia and the University of Pennsylvania School of Medicine, Philadelphia, Pa, and the Division of Medical Genetics
h Department of Medicine, University of Washington, Seattle, Wash
Received for publication May 16, 2005; revisions received June 29, 2005; accepted for publication July 12, 2005. * Address for reprints: Amy H. Schultz, MD, Division of Cardiology, Children's Hospital and Regional Medical Center, 4800 Sand Point Way, W-4841, Seattle, WA 98105 (Email: ahschultz{at}uwalumni.com).
| Abstract |
|---|
|
|
|---|
METHODS: We performed within-family comparison of 11 multiple-gestation births in which one child had congenital heart disease. At 1 year of age, the Bayley Scales of Infant Development II were administered, and growth parameters were assessed. Paired comparisons were made by using fixed effects regression conditioned on family.
RESULTS: The multiple-gestation subjects were mildly premature on average (mean gestational age, 35.4 ± 3.0 weeks). At 1 year of age, children with congenital heart disease scored lower on the Mental Development Index (85.0 ± 19.3 vs 93.9 ± 16.0, P = .037) and the Psychomotor Development Index (76.6 ± 16.9 vs 91.3 ± 14.9, P = .015) on the Bayley Scales of Infant Development II than did their siblings without congenital heart disease. There were no differences between siblings in weight, height, or head circumference.
CONCLUSIONS: The presence of congenital heart disease requiring surgical intervention with cardiopulmonary bypass at 6 months of age or less is associated with a deficit in developmental achievement at 1 year of age, as measured by using the Bayley Scales of Infant Development II.
| Introduction |
|---|
|
|
|---|
| Methods |
|---|
|
|
|---|
Among this cohort, subjects who were the product of a multiple gestation were identified; this group forms the study population for this report. Subjects with microdeletion of chromosome 22q11 were excluded from this study. Siblings of the same gestation were recruited to participate in the follow-up evaluation. Neonatal records of both the subjects with CHD and their siblings were reviewed for information about the pregnancy and perinatal course. Gestational age was recorded in completed weeks by best obstetric estimate.
The Institutional Review Board at The Children's Hospital of Philadelphia approved the study. Written informed consent was obtained from the parent or guardian. The funding agencies had no role in data collection, interpretation, or analysis or in the preparation of the manuscript.
Intraoperative Management
Operations were performed by 3 cardiac surgeons with a dedicated team of cardiac anesthesiologists. Alpha-stat blood gas management was used. Deep hypothermic circulatory arrest (DHCA) was used at the surgeon's discretion. Before DHCA, patients were cooled to a nasopharyngeal temperature of 18°C by a combination of core cooling on CPB and topical hypothermia. Modified ultrafiltration was performed in all patients.
One-Year Follow-up Evaluation
A study follow-up visit was conducted at 12 months of age, corrected for prematurity, plus or minus 2 weeks. Siblings were assessed on the same day. Personnel involved in the evaluation were not blinded to CHD status. One of 3 specialists in developmental pediatrics measured growth parameters and performed a neurologic examination. The same investigator evaluated all children in a family. Length was determined by using a supine board. Neurologic findings were classified as normal, suspect, or abnormal. A single psychologist administered the Bayley Scales of Infant Development II. Each child with CHD was evaluated by a genetic dysmorphologist to identify children with genetic syndromes that might not have been apparent earlier in infancy. Children were eliminated if the geneticist believed there were marked dysmorphisms, even if no named syndrome was diagnosed. SES, as measured by the Hollingshead Index,
10
and ethnicity were determined by means of parental questionnaire.
The Bayley Scales of Infant Development II yields 2 scores: the Mental Development Index (MDI) and the Psychomotor Development Index (PDI). Each of these scores has a mean of 100 and a standard deviation of 15 in the general population. The MDI assesses memory, problem solving, early number concepts, generalization, expressive and receptive language, and social skills. The PDI evaluates control of gross motor functioning, including crawling and walking, as well as fine motor skills necessary for prehension, use of writing instruments, and imitation of hand movements.
Data Analysis and Statistical Methods
As a measure of complexity of CHD, patients were categorized according to a previously described classification that has been shown to be predictive of postoperative mortality.
11
Class I includes patients whose repair achieves a biventricular circulation and in whom there is no preoperative arch obstruction, class II includes patients whose repair achieves a biventricular circulation with arch obstruction, class III includes patients whose repair achieves a single-ventricle circulation without arch obstruction, and class IV includes patients whose repair achieves a single-ventricle circulation with arch obstruction.
Descriptive statistics were used to characterize the study population and other subsets of the larger cohort. Comparisons were made across groups by using t tests, contingency tables, or Wilcoxon rank sum tests. Exact methods were used for contingency tables when any expected value was less than 5. Within the multiple-gestation subjects, the distribution of MDI and PDI scores and growth parameters were inspected, and adequate symmetry was believed to be present to allow the use of parametric tests. Fixed effects regression conditioned on family group was used to make paired comparisons between subjects with CHD and their siblings. This strategy allowed incorporation of the data from both siblings in the sets of triplets. Statistical analyses were performed using STATA 7.0 (College Station, Tex).
The relationship between apolipoprotein E genotype and neurodevelopmental outcome was not explored in the multiple-gestation cohort. The allele associated with increased risk of neurodevelopmental delay,
2, had an allele frequency of approximately 8% in the larger cohort. Thus only 1 or 2 multiple-gestation subjects with CHD and the
2 allele could be expected in this study cohort, a number too small for any meaningful relationships to be identified.
| Results |
|---|
|
|
|---|
Compared with the singleton births in the larger cohort, the multiple-gestation subjects included in this study were more premature (35.4 ± 3.0 vs 38.5 ± 2.1 weeks, P < .001), had a lower birth weight (2.46 ± 0.65 vs 3.14 ± 0.62 kg, P < .001), were more likely to be delivered by means of cesarean section (10/11 vs 136/506, P < .001), and had a higher SES (Hollingshead Index: 4.5 ± 0.7 vs 3.9 ± 1.2, P = .009) than the study subjects who were the product of singleton pregnancies. Mortality in the first year of life was 9 (30%) of 30 among all multiple gestations compared with 39 (7.5%) of 520 for all singleton births (P < .001).
Baseline characteristics of the included and not included multiple-gestation subjects are shown in Table 1. The multiple-gestation subjects not included had more complex CHD than those included, which is not surprising because 9 of those not included died before 1 year of age. Further descriptive information on the multiple-gestation subjects with CHD is shown in Table 2. Four pregnancies were known to be the product of in vitro fertilization; 2 mothers conceived after pharmacologic ovarian stimulation.
|
|
|
|
|
| Discussion |
|---|
|
|
|---|
Rather than comparing MDI and PDI scores with population norms, this study used comparisons within multiple-gestation births to control optimally for SES, parental intelligence, gestational age, and home environment. These potential confounders have been shown to have large effects on cognitive outcomes, effects much greater in magnitude than many interventions studied. For example, social class explained 23.7% of the variance in full-scale IQ scores at 8 years of age in the Boston Circulatory Arrest Trial, whereas assignment to intraoperative support strategy explained only 0.3%.
1
A meta-analysis of twin studies has demonstrated that the heritability of IQ is approximately 50%, whereas in utero environment (20%) and shared postnatal environmental factors (17%) also contribute importantly to explaining variance in IQ.
5,6
Mean cognitive scores of children born prematurely decrease in a linear fashion with decreasing birth weight.
8
Having controlled for these confounders, we observed that children with CHD had deficits in developmental achievement at 1 year of age when compared with their siblings.
The deficits in achievement were observed despite the fact that the majority of the multiple-gestation subjects had CHD that could be corrected to a biventricular circulation in one operation without the use of circulatory arrest. Only 3 children in the study cohort did not have a biventricular repair. The small number of single-ventricle lesions precluded examining the relationship between CHD class and neurodevelopmental outcome. Many of the subjects had the dual vulnerability of both prematurity and CHD. More than half of the subjects required an operation in the neonatal period, which an analysis of the large cohort from which this study population was drawn has suggested might be a period of particular vulnerability to the development of periventricular leukomalacia after CPB.
14
These observations support the hypothesis that neurodevelopmental impairment after infant cardiac surgery is multifactorial in cause. Research in this field needs to address the complex interaction between multiple factors to optimize patient outcomes.
There are limitations to this study. The mechanisms by which CHD and its management are associated with deficits in developmental outcome at 1 year of age cannot be determined by this study. In particular, the effects of CHD, per se, and surgical intervention with CPB cannot be separated from each other. The sample size of the study was small and therefore did not allow precise determination of the magnitude of the difference in MDI and PDI scores.
Correlations between scores on the MDI and PDI at 1 year of age and subsequent achievement are imperfect. In a recent analysis of subjects with D-transposition of the great arteries enrolled in the Boston Circulatory Arrest Trial, correlations between MDI or PDI and achievement or IQ testing at 8 years of age were statistically significant but modest in magnitude (0.16-0.33).
15
Sensitivity of low MDI or PDI scores for low achievement or IQ scores was poor (16%-31%), but specificity was good (82%-93%). Thus the Bayley Scales of Infant Development provide an early assessment of neurodevelopmental status with some correlation with school age performance, but later follow-up is needed. Follow-up of the multiple-gestation cohort at 4 years of age is currently ongoing.
Given that 4 (27%) of 15 potentially eligible multiple-gestation families did not complete follow-up at 1 year, bias could be introduced into the results if those who did return were more or less likely to have neurodevelopmental delay. Although we cannot assess the development of those who did not return, most of the reasons for failure to return seem unlikely to be related to the child's neurodevelopmental status (distance, acute illness, or error on the part of the study staff). The CHD was more severe among these 4 families (3/4 with HLHS or variants) than among those who completed follow-up, making it improbable that inclusion of these families would have reduced the magnitude of the difference observed. Another potential source of bias is that the investigators performing the 1-year evaluation were not blinded to CHD status. This knowledge could have influenced their ratings of subjects' performance on the Bayley Scales and would be predicted to inflate the effect of CHD on neurodevelopmental outcome.
Although the main strength of the study design is the ability to address important confounders, it is possible that residual confounding exists. The sibling control subjects were not consistently evaluated by a geneticist. However, underdiagnosis of genetic syndromes in the siblings would tend to bias the results toward the null hypothesis, and the true magnitude of the differences in MDI and PDI would be expected to be larger than reported here. It is possible that genetic syndromes remain undiagnosed among the children with CHD. We have attempted to minimize this possibility by including a formal genetic evaluation at the 1-year visit.
The cohort studied is more premature and of higher SES than a large cohort of children undergoing infant surgical intervention for CHD at the same institution. There might also be independent effects of multiple gestation, particularly among triplets,
16
on neurodevelopmental outcomes. Thus the ability to generalize these findings to singleton term infants with CHD may be limited. Still, our findings are consistent with patterns observed when cohorts of predominantly singleton term infants are compared with population norms.
4,12
| Summary |
|---|
|
|
|---|
| Footnotes |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
S. H. Snookes, J. K. Gunn, B. J. Eldridge, S. M. Donath, R. W. Hunt, M. P. Galea, and L. Shekerdemian A Systematic Review of Motor and Cognitive Outcomes After Early Surgery for Congenital Heart Disease Pediatrics, April 1, 2010; 125(4): e818 - e827. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Wernovsky Improving neurologic and quality-of-life outcomes in children with congenital heart disease: Past, present, and future J. Thorac. Cardiovasc. Surg., February 1, 2008; 135(2): 240 - 242. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |